MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).

Jan 30, 2025 · Find patient medical information for Mircera (methoxy polyethylene glycol-epoetin beta) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, …

Jun 5, 2024 · Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more …

Indicated for treatment of anemia associated with chronic kidney disease (CKD) in adults on dialysis or not on dialysis. Individualize dose and use lowest dose sufficient to reduce need for …

Oct 17, 2024 · Mircera (Methoxy Polyethylene glycol-epoetin beta) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications …

What is MIRCERA ®? MIRCERA ® is a Continuous Erythropoetin Receptor Activator (C.E.R.A.) indicated for: the treatment of symptomatic anaemia associated with chronic kidney disease …

Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more deaths …

MIRCERA is indicated for the treatment of anaemia associated with chronic kidney disease (CKD). Adult patients on dialysis and adult patients not on dialysis.

Jun 26, 2024 · Mircera is a man-made form of a protein normally produced by the kidneys that helps your body produce red blood cells. When your body does not make enough of this …

What is Mircera? Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called …